Why did TMD.TO stock jump pre-market today?

TMD.TO stock rose pre-market due to heavy trading volume and speculative orders. The intraday swing from **C$0.05** to **C$1.13** increased liquidity and drew momentum traders. No confirmed company press release explained the move at time of writing.

What are the main risks for TMD.TO stock investors?

Main risks include development setbacks for the Enos system, funding and dilution risk, and low daily liquidity outside high-volume spikes. Titan Medical’s small size and early commercial stage raise execution risk for TMD.TO stock.

How does Meyka AI view TMD.TO stock performance?

Meyka AI rates TMD.TO **68.64 / B (HOLD)** based on benchmark and sector comparisons, metrics, and forecasts. The model projects **CAD 1.85** in 12 months versus **CAD 1.125** now, but forecasts are model-based and not guarantees.

What short-term levels should traders watch on TMD.TO stock?

Traders should watch support near **C$0.05**, intraday support at the open, and resistance near **C$1.25** year high. Monitor order book depth and volume to manage fills and slippage for TMD.TO stock.

CA Stocks

TMD.TO Titan Medical: C$1.13 pre-market 09 Mar 2026: monitor heavy volume

ByDanny Kontos March 9, 2026March 9, 2026

TMD.TO stock opened pre-market at C$1.13 on 09 Mar 2026 after a high-volume trade. The move followed an intraday swing from C$0.05 to C$1.13, with 117,220 shares trading versus an average of 45,936. This volume ratio of 2.55x highlights liquidity and short-term trader interest. We examine drivers, fundamentals, and near-term scenarios for Titan Medical Inc. (TMD.TO) on the TSX.